Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 +0.00 (+0.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Other financing activities (2021 - 2023)

Updated

Jasper Therapeutics (JSPR) recorded Other financing activities of $299,000 in Q4 2023.

Analysis

Jasper Therapeutics (JSPR) Other financing activities (2021 - 2023) Analysis & Trends

For FY2023, Jasper Therapeutics reported Other financing activities of $960,000.

  • Annual Other financing activities has a four-year compound annual growth rate of 42.0% (FY2019 to FY2023).
  • Across earlier years, Other financing activities came in at $95.27 million in FY2021 and $235,896 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Jasper Therapeutics 14.47 Mn -111.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -299,000.00
Dec 31, 2021 -5.29 Mn
Sep 30, 2021 95.94 Mn
API Access

Jasper Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=JSPR&period=max&api_key=YOUR_API_KEY